Pykälistö O, Goldberg A P, Brunzell J D
J Clin Endocrinol Metab. 1976 Sep;43(3):591-600. doi: 10.1210/jcem-43-3-591.
To determine whether adipose tissue lipoprotein lipase (LPL) plays a role in the regulation of triglyceride (TG) metabolism in hypothyroidism, the activity of the enzyme was measured in the subcutaneous adipose tissue of six hypothyroid patients before and during therapy with L-thyroxine. The activity of the activated form of the enzyme, measured as heparin elutable LPL, was lower in hypothyroid patients (1.54 +/- 0.93; mU/10(6) cells; mean +/- SD) than in controls (3.26 +/- 1.49; P less than .02) and increased (163 +/- 89%; P less than .01) with treatment to levels comparable to the controls. The total activity of LPL, measured in ammonium hydroxide extracts of acetone ether tissue powders, was in the low normal range in the hypothyroid patients (0.68 +/- 0.42), but not significantly different from normal (1.10 +/- 0.58) and did not increase significantly (92 +/- 105%), with treatment. Plasma post heparin lipolytic activity (PHLA) was low in hypothyroidism and increased (111 +/- 78%; P less than .05) with treatment. These increases in PHLA correlated with the increases in the activity of heparin elutable LPL (r = .88, P less than .05). In all patients fasting plasma TG levels decreased (-43 +/- 25%; P less than .02) after treatment. Serial determination of heparin elutable LPL activity, PHLA, and plasma TG during L-thyroxine treatment revealed a correlation between the per cent changes in PHLA and heparin elutable LPL activity (r = .68, P less than .05), an inverse correlation between plasma TG levels and heparin elutable LPL (r = -0.53,P less than .05) and no correlation between plasma TG and PHLA (r = -0.05). These results suggest that the low PHLA and hypertriglyceridemia of hypothyroidism are related to low adipose tissue LPL activity. All these parameters return to normal after treatment with L-thyroxine and attainment of euthyroidism.
为了确定脂肪组织脂蛋白脂肪酶(LPL)在甲状腺功能减退症患者甘油三酯(TG)代谢调节中是否起作用,我们测定了6例甲状腺功能减退症患者在左甲状腺素治疗前及治疗期间皮下脂肪组织中该酶的活性。以肝素可洗脱LPL来衡量,甲状腺功能减退症患者中该酶活化形式的活性(1.54±0.93;mU/10⁶细胞;平均值±标准差)低于对照组(3.26±1.49;P<0.02),且治疗后升高(163±89%;P<0.01)至与对照组相当的水平。用氢氧化铵提取丙酮乙醚组织粉末测定的LPL总活性,在甲状腺功能减退症患者中处于正常低限范围(0.68±0.42),但与正常水平(1.10±0.58)无显著差异,且治疗后未显著升高(92±105%)。甲状腺功能减退症患者的血浆肝素后脂解活性(PHLA)较低,治疗后升高(111±78%;P<0.05)。这些PHLA的升高与肝素可洗脱LPL活性的升高相关(r = 0.88,P<0.05)。所有患者治疗后空腹血浆TG水平下降(-43±25%;P<0.02)。在左甲状腺素治疗期间连续测定肝素可洗脱LPL活性、PHLA和血浆TG,结果显示PHLA的变化百分比与肝素可洗脱LPL活性之间存在相关性(r = 0.68,P<0.05),血浆TG水平与肝素可洗脱LPL呈负相关(r = -0.53,P<0.05),而血浆TG与PHLA之间无相关性(r = -0.05)。这些结果提示,甲状腺功能减退症患者的低PHLA和高甘油三酯血症与脂肪组织LPL活性降低有关。用左甲状腺素治疗并使甲状腺功能恢复正常后,所有这些参数均恢复正常。